EGFR and lung carcinoma: Similar results were obtained with several cell lines harboring either an exon 19 deletion (HCC827 and HCC2935) (Figs 3D and E, and EV2A–C) or an exon 21 L858R point mutation (H3255) (Figs 3F and EV2D), which together account for more than 85% of all activated EGFR mutations found in human lung cancers.